Timothy P. Reilly - Net Worth and Insider Trading

Timothy P. Reilly Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Timothy P. Reilly owns 1 companies in total, including HOOKIPA Pharma Inc (HOOK) .

Click here to see the complete history of Timothy P. Reilly’s form 4 insider trades.

Insider Ownership Summary of Timothy P. Reilly

Ticker	Comapny	Transaction Date	Type of Owner
HOOK	HOOKIPA Pharma Inc	2022-04-15	director

Timothy P. Reilly Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Timothy P. Reilly Ownership Network

Ownership Network List of Timothy P. Reilly

No Data

Ownership Network Relation of Timothy P. Reilly

Timothy P. Reilly Owned Company Details

What does HOOKIPA Pharma Inc do?

Who are the key executives at HOOKIPA Pharma Inc?

Timothy P. Reilly is the director of HOOKIPA Pharma Inc. Other key executives at HOOKIPA Pharma Inc include director & Chief Financial Officer Reinhard Kandera , director & Chief Executive Officer Jorn Aldag , and Chief Medical Officer Katia Schlienger .

HOOKIPA Pharma Inc (HOOK) Insider Trades Summary

Over the past 18 months, Timothy P. Reilly made no insider transaction in HOOKIPA Pharma Inc (HOOK). Other recent insider transactions involving HOOKIPA Pharma Inc (HOOK) include a net purchase of 27,000 shares made by Reinhard Kandera , and a net purchase of 20,000 shares made by Jorn Aldag .

In summary, during the past 3 months, insiders sold 0 shares of HOOKIPA Pharma Inc (HOOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of HOOKIPA Pharma Inc (HOOK) were sold and 4,700 shares were bought by its insiders, resulting in a net purchase of 4,700 shares.

HOOKIPA Pharma Inc (HOOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

HOOKIPA Pharma Inc Insider Transactions

No Available Data

Timothy P. Reilly Mailing Address

Above is the net worth, insider trading, and ownership report for Timothy P. Reilly. You might contact Timothy P. Reilly via mailing address: C/o Hookipa Pharma Inc., 350 Fifth Avenue, 72nd Floor, Suite 7240, New York Ny 10018.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.